Modular Medical Statistics
Total Valuation
Modular Medical has a market cap or net worth of $33.87 million. The enterprise value is $29.17 million.
Important Dates
The next estimated earnings date is Friday, February 13, 2026, after market close.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Modular Medical has 77.68 million shares outstanding. The number of shares has increased by 60.52% in one year.
| Current Share Class | 77.68M |
| Shares Outstanding | 77.68M |
| Shares Change (YoY) | +60.52% |
| Shares Change (QoQ) | +2.37% |
| Owned by Insiders (%) | 4.87% |
| Owned by Institutions (%) | 21.13% |
| Float | 69.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 12.77 |
| PB Ratio | 3.04 |
| P/TBV Ratio | 3.86 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.47, with a Debt / Equity ratio of 0.07.
| Current Ratio | 1.47 |
| Quick Ratio | 1.32 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -308.87% and return on invested capital (ROIC) is -176.72%.
| Return on Equity (ROE) | -308.87% |
| Return on Assets (ROA) | -140.64% |
| Return on Invested Capital (ROIC) | -176.72% |
| Return on Capital Employed (ROCE) | -273.96% |
| Weighted Average Cost of Capital (WACC) | 3.17% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$448,574 |
| Employee Count | 54 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Modular Medical has paid $2,000 in taxes.
| Income Tax | 2,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.66% in the last 52 weeks. The beta is -0.19, so Modular Medical's price volatility has been lower than the market average.
| Beta (5Y) | -0.19 |
| 52-Week Price Change | -65.66% |
| 50-Day Moving Average | 0.42 |
| 200-Day Moving Average | 0.66 |
| Relative Strength Index (RSI) | 47.85 |
| Average Volume (20 Days) | 233,746 |
Short Selling Information
The latest short interest is 402,098, so 0.52% of the outstanding shares have been sold short.
| Short Interest | 402,098 |
| Short Previous Month | 379,827 |
| Short % of Shares Out | 0.52% |
| Short % of Float | 0.58% |
| Short Ratio (days to cover) | 0.95 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -24.47M |
| Pretax Income | -24.22M |
| Net Income | -24.22M |
| EBITDA | -23.06M |
| EBIT | -24.47M |
| Earnings Per Share (EPS) | -$0.51 |
Full Income StatementBalance Sheet
The company has $5.32 million in cash and $611,000 in debt, with a net cash position of $4.71 million or $0.06 per share.
| Cash & Cash Equivalents | 5.32M |
| Total Debt | 611,000 |
| Net Cash | 4.71M |
| Net Cash Per Share | $0.06 |
| Equity (Book Value) | 8.77M |
| Book Value Per Share | 0.14 |
| Working Capital | 1.90M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$19.19 million and capital expenditures -$3.20 million, giving a free cash flow of -$22.38 million.
| Operating Cash Flow | -19.19M |
| Capital Expenditures | -3.20M |
| Free Cash Flow | -22.38M |
| FCF Per Share | -$0.29 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
